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We investigated the role of nutritional risk index (NRI) in predicting 1-year mortality in
patients with acute decompensated heart failure (ADHF).
Methods
Among 5,625 cohort patients enrolled in Korean Acute Heart Failure (KorAHF) Registry, a
total of 5,265 patients who were possible to calculate NRI [NRI = (1.519 x serum albumin
[g/dl]) + (41.7 x weight [kg]/ideal body weight [kg])] were enrolled. The patients were divided
into 4 groups according to the NRI quartile; Q1 <89 (n = 1121, 69.9 ± 14.5 years, 632 males),
Q2 89–95 (n = 1234, 69.7 ± 14.4 years, 677 males), Q3 95–100 (n = 1199, 68.8 ± 14.0 years,
849 males), Q4 >100 (n = 1711, 65.6 ± 14.5 years, 779 males). Primary end-point was all-
cause mortality at 1-year clinical follow-up.
Results
The 1-year mortality was significantly increased as the NRI quartile decreased, and the low-
est NRI quartile was associated with the highest 1-year mortality (Q1: 27.5% vs. Q2: 20.9%
vs. Q3: 12.9% vs. Q4: 8.7%, linear p <0.001). On Kaplan-Meier survival analysis, the signifi-
cant inter-quartile difference was observed (p <0.001 for all). In multivariate analysis using
Cox proportional hazard regression, the lowest NRI quartile was an independent predictor
of 1-year mortality in patients with ADHF.
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Conclusions
Poor nutritional status as assessed by NRI and quartile grading of NRI was associated with
1-year mortality in Korean patients with ADHF. The assessment of nutritional status by NRI
may provide additional prognostic information and thus would be useful in the risk stratifica-
tion of the patients with ADHF.
Introduction
Nutrition has been an essential risk factor in various cardiovascular diseases. There are num-
bers of evidences that nutritional status affects development of heart failure (HF) as well as its
clinical outcomes. Malnutrition may result in cardiac remodeling and worsening of HF by
promoting the production of catabolic cytokines, such as TNF-α, interleukin-6 and interlukin-
1β that may lead to inflammation [1, 2]. Vice versa, an imbalance between anabolic and cata-
bolic processes in patients with HF can cause malnutrition [3]. Despite these close association
between nutritional status and HF, there is a difficulty in the diagnosis of malnutrition and
cachexia in patients with HF because of body weight gain due to edema or excessive extracellu-
lar fluid in this clinical setting.[4]
The previous studies have shown that albumin or body mass index (BMI) which can reflect
a nutritional status is associated with adverse clinical outcomes in various cardiovascular dis-
eases [5–9]. However, the evaluation of nutritional status by single parameter such as albumin
or BMI may not reflect nutritional status of the patients precisely. To overcome the limitations
of single parameter approach, several indices or scoring systems were proposed and have been
used to evaluate nutritional status. Nutritional risk index (NRI) is a commonly used method to
evaluate the nutritional status of the elderly [10], and controlling nutritional status or Ulibarri’s
method (CONUT) score which incorporate serum albumin, cholesterol levels, and lymphocyte
counts is also a useful tool for evaluating nutritional status [11]. Some studies evaluated the
usefulness of CONUT score in patients with HF and demonstrated that CONUT score can
predict poor outcome in terms of HF and non-HF readmissions, independently of body mass
index (BMI) [12] and is useful for predicting the long-term prognosis of hospitalized patients
with HF, especially in elderly population [13, 14]. However, the role of NRI has been poorly
evaluated in a cohort of patients with acute decompensated heart failure (ADHF). Therefore,
the aim of this study was to investigate the impacts of NRI on long-term clinical outcomes in
patients with ADHF. The usefulness of NRI in predicting 1-year mortality in patients with
ADHF was also compared to that of CONUT score.
Materials and methods
Study population
A total of 5,625 consecutive hospitalized patients for ADHF from 10 tertiary university hospi-
tals were enrolled in Korean Acute Heart Failure (KorAHF) from March 2011 to February
2014 with a planned follow-up period through 2016. Patients who have signs or symptoms of
HF and one of the following criteria are eligible for the study: (i) lung congestion or (ii) objec-
tive findings of LV systolic dysfunction or structural heart disease. Lung congestion has been
defined as ‘congestion’ on a chest X-ray or as rales on physical examination. There are no
exclusion criteria. The patients were classified into de novo (new-onset acute HF in a patient
without previously known cardiac dysfunction), acute decompensation of chronic HF, or five
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clinical profiles (acute decompensated HF, hypertensive HF, pulmonary edema, cardiogenic
shock, and right HF) by the attending physician according to the 2005 European Society of
Cardiology (ESC) guidelines.[15] The class of high-output HF was not recorded. The study
protocol was approved by the ethics committee at each hospital: Chonnam National University
Hospital; Seoul National University Hospital; Samsung Medical Center; Asan Medical Center;
Chungbuk National University hospital; Kyungpook National University hospital; Catholic
University St. Mary’s Hospital; Yonsei University Severance Hospital; Seoul National Univer-
sity Bundang Hospital; Wonju Christian Hospital.
Among 5,625 ADHF cohort patients, a total of 5,265 patients who were possible to calculate
NRI were incorporated into analysis. The patients were divided into 4 groups according to
NRI quartile; Q1<89 (n = 1121, 69.9 ± 14.5 years, 632 males), Q2 89–95 (n = 1234, 69.7 ± 14.4
years, 677 males), Q3 95–100 (n = 1199, 68.8 ± 14.0 years, 849 males), Q4>100 (n = 1711,
65.6 ± 14.5 years, 779 males) (Fig 1). Primary endpoint was all-cause mortality and secondary
endpoint was rehospitalization at 1-year clinical follow-up. Composite endpoint was all-cause
mortality and rehospitalization at 1-year clinical follow-up.
Data collection
As described in detail previously[16], written informed consents were obtained from all patients. If
patients were unable to give consent due to disease severity, informed consent was obtained from a
relative or legal representative. The attending physician completed a web-based case report form in
the Clinical Data Management System (iCReaT) from the Korea National Institute of Health
(NIH) with the assistance of a clinical research coordinator. The detailed variables and values col-
lected at baseline admission and case definition are described in elsewhere.[16] If the patients were
Fig 1. Study flow. KorAHF = Korea acute heart failure; NRI = nutritional risk index.
https://doi.org/10.1371/journal.pone.0209088.g001
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admitted via an emergency department (ED), the initial presentation and laboratory results at the
ED are included in the baseline data. Echocardiographic exam was performed during the first few
days of admission. After discharge, events including all-cause death, death from HF aggravation,
and re-hospitalization for HF aggravation are recorded. The latest information on a patient’s clini-
cal manifestation, biochemistry, and medication is collected at the first re-visit in 30 days, and at 3,
6, 12, 24, 36, 48, and 60 months. The follow-up data were collected from the patients by the attend-
ing physician and stored in the web-based case report form. The outcome data for subjects who
had not been followed up have been ascertained by a telephone interview. In addition, the outcome
data for patients lost to follow-up will be collected from the National Death Records.
Definitions
Malnutrition was defined as the lowest quartile of NRI. NRI was calculated as: NRI = (1.519 x
serum albumin [in g/dl] + (41.7 x weight [in kg] / ideal body weight [in kg]). The ideal body
weight (IBW) was calculated was the Devine formula for men (IBW [kg] = 50 kg + 2.3 kg for
each inch of height > 5 feet) and the Robinson formula for women (IBW [kg] 48.67 kg + 1.65
kg for each inch of height over 5 feet).[17] BMI was defined as weight in kilograms divided by
height in meters squared (kg/m2) and obesity was defined as a BMI of 30.0.
CONUT score and Prognostic Nutritional Index (PNI) were also used to evaluate the nutri-
tional status in patients with HF. CONUT score system was developed for hospitalized
patients[11]. It thus enables evaluation of the protein reserves, calorie depletion, and immune
defenses, respectively (Table 1). We classified the patients according to the CONUT score as:
normal nutritional status (CONUT 0–1 points), mild malnutrition (CONUT score 2–4 points)
and moderate to severe malnutrition (CONUT score� 4 points). PNI was calculated as 10 x
albumin level (g/dL) + 0.005 x lymphocyte count (/uL).
Statistical analysis
Continuous variables with normal distributions are presented as mean ± standard deviation
and were compared using the student’s t-test or Mann-Whitney U test when group distribu-
tions were skewed. Categorical variables were compared using the chi-square test or Fisher’s
exact test, where appropriate. The comparison of baseline characteristics and echocardiographic
findings according to NRI quartile were performed using one-way analysis of variance. ROC-
curve analysis was performed to compare NRI with CONUT score. COX proportional hazard
regression was used to determine the independent predictors of 1-year mortality in patients
with ADHF. Variables with p<0.1 on univariate regression analysis and clinically relevant vari-
ables were analyzed. All statistical tests were two-tailed and p value<0.05 were considered sig-
nificant. Statistical analyses were performed using the Statistical Package for Social Sciences,
version 18.0 (SPSS, PC version, Chicago, Illinois) and the comparisons of ROC curves were per-
formed by use of MedCalc, version 16.8.4 (MedCalc Software bvba, Ostend, Belgium).
Results and discussion
Baseline characteristics of study population
Malnutrition in ADHF patients was not uncommon and the total number of the lowest NRI
quartile was 1,121 out of 5,265 (21.3%). Demographic characteristics of NRI quartiles are sum-
marized in Table 1. Patients with lower NRI quartiles were older and more likely to be female.
BMI and body surface area were higher in the highest NRI quartile. Baseline heart rate, history
of hypertension, and diabetes were not different among groups. Patients with the highest NRI
quartile had the most frequent history of dyslipidemia, smoking history, and alcohol.
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Laboratory findings and echocardiographic findings
Laboratory findings among NRI quartiles are summarized in Table 2. Patients with the lowest
NRI quartile had lower sodium concentration and hemoglobin level, but higher serum blood
urea nitrogen and creatinine with lower glomerular filtration rate. Lipid profiles were all highest
in patients with the highest NRI quartile. NT-proBNP had inverse relationship with NRI quartiles
and the highest level of high-sensitivity C-reactive protein was noted in the lowest NRI quartile.
Echocardiographic findings according to NRI quartiles are summarized in Table 3. LV dia-
stolic and systolic chamber size and LVEF were higher in the highest NRI quartile, possibly
reflecting lower volume status in the lowest NRI quartile. Patients in the highest NRI quartile
also showed higher e’ and thus lower E/e’ and lower systolic pulmonary artery pressure reflect-
ing better LV diastolic function. Among those variables mentioned above, NRI had a correla-
tion between LVEF (r = 0.031, p = 0.026), LVEDD (r = -0.113,<0.001), NT-proBNP r = -0.301,
<0.001) and hsCRP (r = -0.283,<0.001), which were not so strong.
Medical treatment according to the NRI quartiles
The comparison of discharge medications according to the NRI quartiles are summarized in
Table 4. Patients in the lowest NRI quartile used ACE inhibitor, ARB, and beta-blockers least.
















Age (years) 68.4±14.5 69.9±14.5 69.7±14.4 68.8±14.0 65.6±14.5 <0.001
Male sex (n, %) 2782 (52.8) 632 (49.8) 677 (52.3) 849 (54.1) 779 (55.7) 0.001
Height (cm) 160.4±9.6 159.9±9.1 159.9±9.8 160.7±9.5 161.1±9.6 0.002
Weight (kg) 60.4±13.1 54.2±12.2 58.6±12.1 62.8±12.4 64.9±12.7 <0.001
Body mass index (kg/m2) 23.4±3.9 21.1±3.9 22.8±3.6 24.2±3.6 24.9±3.5 <0.001
Body surface area (m2) 1.6±0.2 1.6±0.2 1.6±0.2 1.7±0.2 1.7±0.2 <0.001
NYHA class III-IV 4706 (85.1) 1117 (88.1) 1128 (87.1) 1324 (84.3) 1137 (81.3) <0.001
Ischemic etiology 2077 (37.6) 516 (40.7) 483 (37.3) 588 (37.5) 490 (35.1) 0.005
Systolic blood pressure (mmHg) 132.0±30.2 128.5±31.0 129.3±30.4 132.4±29.3 134.1±30.6 <0.001
Diastolic blood pressure (mmHg) 79.1±18.6 76.6±18.6 77.5±18.5 79.3±19.2 80.8±18.5 <0.001
Heart rate (bpm) 92.5±25.9 93.4±25.2 91.9±26.2 93.2±26.8 91.9±25.6 0.261
NRI (points) 95.6±8.7 82.8±5.3 92.0±1.7 97.6±1.6 104.3±3.1 <0.001
CONUT score (points) 2.5±2.0 4.6±2.1 2.6±1.6 1.8±1.2 1.5±1.5 <0.001
PNI (points) 45.3±7.2 39.2±7.3 43.7±5.6 46.7±4.4 52.3±5.1 <0.001
Hypertension 3109 (59.1) 735 (58.0) 741 (57.2) 955 (60.8) 839 (60.0) 0.099
Diabetes mellitus 1861 (35.3) 466 (36.8) 431 (33.3) 595 (37.9) 466 (33.3) 0.362
Dyslipidemia 2125 (40.4) 438 (38.3) 462 (39.6) 651 (45.7) 617 (48.6) <0.001
Smoking history 2030 (38.6) 460 (36.3) 488 (37.7) 623 (39.7) 566 (40.5) 0.014
Alcohol history 2023 (38.4) 434 (34.2) 450 (34.7) 608 (38.7) 630 (45.1) <0.001
Obesity 273 (5.2) 29 (2.3) 51 (3.9) 101 (6.4) 100 (7.2) <0.001
Cerebrovascular disease 784 (14.9) 215 (17.0) 199 (15.4) 237 (15.1) 181 (12.9) 0.005
Ischemic heart disease 1461 (27.7) 371 (29.3) 370 (28.6) 473 (30.1) 346 (24.8) 0.030
Chronic kidney disease 734 (13.9) 253 (20.0) 207 (16.0) 214 (13.6) 115 (8.2) <0.001
Atrial fibrillation 1456 (27.7) 291 (22.9) 370 (28.6) 453 (28.9) 405 (29.0) 0.001
Values are mean±SD. NRI, nutritional risk index.
https://doi.org/10.1371/journal.pone.0209088.t001
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However, nitrate was most frequently used in the lowest NRI quartile. Guideline-based HF
treatment, such as ACE inhibitor, ARB, or beta-blockers was most infrequently used in the
lowest NRI quartile. Statin was used most frequently in the highest NRI quartile. Amiodarone
was used more commonly in the higher NRI quartile, but this showed no significant statistical
difference. Digoxin tended to be used in the lower NRI quartile despite lower incidence of
atrial fibrillation in the lowest NRI quartile (Table 1).
















QRS duration (msec) 106.3±28.8 102.8±25.8 106.8±29.8 108.4±30.9 108.7±28.6 <0.001
White blood cell (/uL) 8568.6±4001.6 9001.1±4845.3 8560.2±3821.5 8447.2±3875.6 8724.2±3783.5 0.003
Sodium (mEq/L) 137.6±4.7 136.4±5.3 136.8±5.1 138.0±4.5 138.7±4.1 <0.001
Hemoglobin (g/dL) 12.4±2.3 11.4±2.2 12.1±2.2 12.6±2.2 13.5±2.1 <0.001
Platelet (x1000/uL) 211.2±86.2 217.1±98.6 207.8±87.7 206.5±91.8 210.6±76.8 0.010
Blood urea nitrogen (mg/dl) 25.8±15.9 29.5±19.0 27.9±16.9 25.8±16.4 22.2±12.4 <0.001
Creatinine (mg/dl) 1.5±1.5 1.7±1.9 1.5±1.5 1.4±1.3 1.3±1.1 <0.001
GFR (ml/min) 73.8±39.3 69.0±43.2 70.2±37.8 72.5±37.3 79.9±38.1 <0.001
CK-MB (ng/mL) 8.0±27.4 9.4±29.7 10.4±56.5 8.4±28.8 9.9±44.1 0.620
Cardiac Troponin-I (ng/mL) 2.3±17.8 4.1±27.1 2.5±18.6 2.6±16.7 2.3±16.1 0.148
Glucose (mg/dl) 154.3±76.0 161.5±83.5 157.1±79.5 153.7±75.3 150.8±69.8 0.003
Hb A1c (%) 6.8±1.4 6.9±1.5 6.8±1.4 6.7±1.4 6.6±1.2 0.015
Total Cholesterol (mg/dl) 152.2±42.9 142.9±46.5 145.1±40.7 152.0±39.5 164.9±43.0 <0.001
Triglycerides (mg/dl) 99.4±59.1 93.3±53.6 90.1±48.4 98.0±58.4 112.3±68.3 <0.001
HDL cholesterol (mg/dl) 41.7±13.8 37.7±14.5 41.6±15.4 41.6±13.0 43.9±12.7 <0.001
LDL cholesterol (mg/dl) 93.8±37.0 89.4±39.5 88.1±33.8 93.2±34.8 100.6±39.1 <0.001
NT-proBNP (pg/ml) 4736 (2086–11313) 10519 (4040–23750) 6477 (3131–13633) 4085 (1971–9511) 2844 (1273–5865) <0.001
hsCRP (mg/dl) 0.65 (0.20–2.28) 1.83 (0.53–5.48) 0.85 (0.30–3.02) 0.54 (0.18–1.65) 0.30 (0.11–0.92) <0.001
Values are mean±SD. NRI, nutritional risk index; GFR, glomerular filtration rate; CK, Creatinine Kinase; Hb, hemoglobin; HDL, high-density lipoprotein; LDL, Low-
density lipoprotein; NT-proBNP, N-terminal pro B-type natriuretic peptide; hsCRP, high-sensitivity C-reactive protein
https://doi.org/10.1371/journal.pone.0209088.t002
















LVEF (%) 38.1±15.6 37.5±15.5 37.0±15.5 37.9±15.6 38.8±15.8 0.022
LVEDD (mm) 57.4±10.0 55.3±9.9 57.8±10.2 57.9±10.1 58.2±9.9 <0.001
LVESD (mm) 45.1±12.4 43.6±11.9 45.6±12.6 45.5±12.4 45.4±12.5 <0.001
Left atrial diameter (mm) 48.3±9.8 46.0±9.9 48.6±9.8 49.2±9.3 48.5±10.2 <0.001
E velocity (m/s) 0.94±0.39 0.91±0.37 0.98±0.39 0.97±0.42 0.90±0.36 <0.001
e’ velocity (cm/s) 5.0±2.3 4.9±2.1 4.9±2.2 5.0±2.1 5.2±2.8 0.005
E/e’ 21.2±11.4 21.3±11.4 22.4±12.1 21.7±12.0 19.5±10.1 <0.001
Systolic pulmonary artery pressure (mmHg) 43.8±15.1 45.2±14.3 45.5±15.3 44.6±15.5 40.8±14.5 <0.001
Values are mean±SD. NRI, nutritional risk index; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic dimension; LVESD, left ventricular end
systolic dimension; E, early diastolic velocity of mitral inflow; e’, early diastolic mitral annular velocity
https://doi.org/10.1371/journal.pone.0209088.t003
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Clinical outcomes according to NRI quartiles
There were significant differences in one-year mortality among NRI quartiles (from the lowest
to highest quartile: 26.8% vs. 21.8% vs. 13.9% vs. 9.1%, linear p<0.001). Kaplan-Meier survival
curves showed the highest 1-year mortality in patients with the lowest NRI quartile (Fig 2A).
However, rehospitalization-free survival was not different among NRI quartiles (from the low-
est to highest quartile: 46.8% vs. 46.5% vs. 50.7% vs. 47.0%, p = 0.110) (Fig 2B). Composite
endpoint was more frequently observed in lower NRI quartiles (NRI<95) (Fig 2C).
In multivariate analysis using COX proportional hazard regression showed the lowest NRI
quartile (NRI<89) was an independent predictor of 1-year mortality in patients with ADHF
(HR 1.84, 95% CI 1.50–2.27, p<0.001) (Table 5).
NRI showed different impact on risk stratification of obesity. In high NRI group (NRI
�95), patients with BMI>30 kg/m2 showed better survival than those with BMI�30 kg/m2.
However, there was no difference in low NRI group (NRI<95) (Fig 3).
















ACE inhibitor 1560 (29.6) 323 (25.5) 386 (29.8) 416 (26.5) 449 (32.1) 0.003
Angiotensin receptor blocker 2091 (39.7) 432 (34.1) 452 (34.9) 648 (41.3) 570 (40.8) <0.001
Beta blocker 2749 (52.2) 572 (45.1) 638 (49.3) 809 (51.5) 742 (53.1) <0.001
Nitrate 1192 (22.6) 322 (25.4) 328 (25.3) 329 (21.0) 238 (17.0) <0.001
Furosemide 3829 (72.7) 837 (66.0) 954 (73.7) 1144 (72.9) 989 (70.7) 0.019
Amiodarone 381 (7.2) 94 (7.4) 93 (7.2) 120 (7.6) 114 (8.2) 0.402
Digoxin 1379 (26.2) 330 (26.0) 353 (27.3) 411 (26.2) 319 (22.8) 0.042
Warfarin 1557 (29.6) 261 (20.6) 383 (29.6) 486 (31.0) 438 (31.3) <0.001
Aspirin 2901 (55.1) 675 (53.2) 671 (51.8) 854 (54.4) 770 (55.1) 0.174
Statin 2247 (42.7) 459 (36.2) 497 (38.4) 684 (43.6) 649 (46.4) <0.001
No use of beta blocker or RASI 3134 (59.5) 853 (67.3) 811 (62.6) 930 (59.2) 799 (57.2) <0.001
Values are mean±SD. NRI, nutritional risk index; ACE, angiotensin converting enzyme; RASI, renin-angiotensin system inhibitor
https://doi.org/10.1371/journal.pone.0209088.t004
Fig 2. (A) Kaplan-Meier survival curves for 1-year mortality according to NRI quartiles. (B)Kaplan-Meier survival curves for rehospitalization-free survival according to
NRI quartiles. (C)Kaplan-Meier survival curves for composite endpoint according to NRI quartiles. NRI = nutritional risk index.
https://doi.org/10.1371/journal.pone.0209088.g002
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ROC curve analysis for 1-year mortality
ROC-curve analysis showed that NRI (AUC = 0.653, p<0.001 vs. all) predicted mortality better
than albumin only (AUC = 0.628), BMI (AUC = 0.611), or CONUT score (AUC = 0.594) in
patients with ADHF (Fig 4).
NRI showed a sensitivity of 67.8% and specificity of 55.9% for prediction of 1-year mortality
with the cut-off value of 96.24.
Discussion
The present study investigated the impacts of nutritional status on clinical outcomes in
patients with ADHF and demonstrated several important findings. First, poor nutritional sta-
tus is not uncommon in patients with ADHF (NRI Q1 21.3%). Second, the lowest NRI quartile
is associated with the highest 1-year mortality and 1-year mortality is significantly increased as
the NRI quartile decreased in patients with ADHF. Third, ROC curve analysis suggested that
NRI would be a better tool for evaluating nutritional status in patients with ADHF than any
other variables such as albumin, BMI, or CONUT score. Fourth, NRI is an independent pre-
dictor of long-term mortality even after adjusting for a number of clinically relevant variables.
To the best of our knowledge, this is the largest study that investigates the impacts of NRI on
clinical outcomes in a large population of AHF cohort. Therefore, the present study suggested
that the evaluation of nutritional status should be incorporated in the risk stratification of the
patients with HF and NRI would be a simple and useful tool for this purpose.
The role of nutritional status in risk scoring system: CONUT vs. NRI
In the present study, NRI predicted HF mortality as a single variable calculated only with serum
albumin and body weight. Although NRI has such a simpler calculation than other detailed
Table 5. Independent predictors for 1-year mortality in patients with acute heart failure.
Variables Hazard ratio 95% CI p value
Age >75 years 1.78 1.46–2.18 <0.001
NYHA Fc IV 1.24 0.92–1.67 0.150
Systolic blood pressure<100 mmHg 1.41 1.10–1.80 0.007
Renal dysfunction 1.48 1.19–1.83 <0.001
LVEF <30% 1.14 0.92–1.41 0.222
Na+ <135 mEq/L 1.63 1.34–1.99 <0.001
Hemoglobin <10 g/dL 1.12 0.878–1.43 0.365
Nutritional Risk Index <89 1.84 1.50–2.27 <0.001
Uric acid >7.5 mg/dL 1.12 0.91–1.38 0.280
High BNP level 1.38 1.13–1.68 <0.001
Hypertension 1.16 0.94–1.43 0.178
Diabetes mellitus 0.85 0.70–1.05 0.128
Smoking 1.13 0.92–1.37 0.246
QRS duration 1.00 1.00–1.01 0.079
E/e’ 1.01 1.00–1.02 0.002
High-sensitivity C-reactive protein 1.02 1.00–1.04 0.090
No use of beta blocker or RASI 1.39 1.38–2.13 0.002
Values are mean±SD. NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; BNP, brain
natriuretic peptide; RASI, renin-angiotensin system inhibitor
https://doi.org/10.1371/journal.pone.0209088.t005
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nutritional indices, such as Subjective Global Assessment [18] and Mini Nutritional Assessment
[19] including dietary intake, weight change, and physical examination findings of muscle and
fat, it has more powerful effect in predicting outcomes. NRI itself is a strong independent pre-
dictor for HF mortality even when adjusted by other important variables (Table 5). In addition,
NRI in the present study showed better predictability for long-term mortality than other vari-
ables which reflect nutritional status such as albumin, BMI. Every risk scoring system for
ADHF patients may need NRI in their scoring system. Although Seattle HF model has been a
decent one for prediction of survival in HF[20], NRI components such as albumin and body
weight were not included in the model. Modified TIMI risk index also applied to prediction of
mortality at 120 days in AHF patients[21]. However, this score system required heart rate, age,
and systolic BP, but not nutritional index. Incorporating NRI into those systems may strengthen
the ability to predict prognosis in ADHF. Recently, CONUT score is being used in many stud-
ies[12, 22–24]. However, NRI was superior compared with CONUT score in the present study.
The study by Narumi and colleagues had a smaller number of patients compared to our study
(n = 388 vs. n = 5,265) and the predictive power was not compared between risk score system
with ROC curve analysis. In multivariate analysis, p-value for CONUT score and NRI was same
and the hazard ratio of NRI was relatively high as 6.0. Aggravation of HF may result in general-
ized edema and serum albumin level decreased in the setting of body fluid excess. These rela-
tionship of two components may increase the predictive value of NRI not only for nutritional
status but also for HF status. This concept may be an explanation for the reason why NRI could
predict HF mortality. CONUT score.
Nutritional status and LV diastolic function
In the present study, e’, E/e’, and systolic pulmonary artery pressure were all better in the high-
est NRI quartile. Since diastolic dysfunction is not uncommon and important prognostic fac-
tor in patients with ADHF, this also should be illuminated. Wang et al. reported that bone
mineral density was associated with LV diastolic function in women[25]. However, in a study
of 31,334 apparently healthy Korean adults who underwent echocardiography, Park et al.
reported that LV diastolic dysfunction was more frequent in patients with higher BMI[26].
Although higher NRI does not necessarily mean higher BMI or obesity, diastolic dysfunction
Fig 3. Comparison of death-free survival between patients with body mass index> 30 kg/m2 versus� 30 kg/m2 in high nutritional risk index (A) and low nutritional risk
index (B).
https://doi.org/10.1371/journal.pone.0209088.g003
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and NRI in our result had positive correlation. Another explanation for this relationship
would be sarcopenia. Sarcopenia, which is often accompanied by malnutrition, reportedly
contributes to the muscle weakness and diastolic dysfunction in heart failure[27].
The relationship of NRI and obesity in ADHF
Attempts have been made for the explanation of better clinical outcomes in HF patients with
higher NRI quartile by obesity paradox. In the present study, obesity was most frequently
Fig 4. Receiver operating characteristics-curve analysis among variables associated with nutrition. CONUT = COntrolling NUTritional.
https://doi.org/10.1371/journal.pone.0209088.g004
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observed in the highest NRI quartile (Table 1). Also, there was statistically significant linear
trend of increased incidence of obesity according to increasing NRI score. Although there
were only 5.4% of patients with obesity in total study population, indeed BMI was increased
along higher NRI quartile. Even a patient does not meet obesity criteria, BMI and nutritional
status may be collinear according to a study of 244 very old HF patients[28]. It has been rep-
orted that obesity itself may be protective in HF, because it may be a marker of nutrition and
activate less tumor necrosis factor-alpha which worsens heart failure[29]. Obesity paradox in
HF was demonstrated in numerous studies including that of Shah et al.[30] They concluded
that a lower BMI was associated with age, disease activity, and a higher risk of death in ADHF.
However, in subgroup analysis obesity paradox existed only in older age (>75 years), lower LV
systolic function (LVEF <50%), non-diabetics, and de-novo HF. In the present study, obesity
paradox was evident only in patients in higher NRI group (Fig 3). This indicate that NRI may
give a clue for interpretation of obesity paradox in patients with HF.
Study limitations
The present study has several limitations. First, this was not a randomized-controlled study.
However, Cox proportional hazard method showed that NRI independently predicted 1-year
mortality and our study is the largest prospective cohort that investigated the effect of NRI on
post-discharge outcomes in AHF patients to our best knowledge. Second, the formula for cal-
culating ideal body weight is not standardized to date. Third, the prognostic significance of
NRI in chronic phase of HF has been already shown in a previous study [31]. Body weight is
difficult to measure on admission and not always reliable because of peripheral edema. There-
fore, body weight reflects body fluid volume rather than nutritional status in acute phase of
HF. However, this difference of body weight is not so great and relatively similar to each other.
Thus the impact on outcome may not be changed. Fourth, from the ROC curve analysis, AUC
values of NRI and CONUT were 0.653 and 0.594, respectively, and both were not highly
enough as prognostic markers. However, NRI were superior to CONUT score or PNI in this
study population. Combination of more than two prognostic markers including NRI would be
warranted in the future study so that we might overcome the limitation of low AUC level.
Fifth, since we included only East Asians, we do not know whether the study results can be
extrapolated to other ethnicities. Finally, due to the nature of the study design, the study results
are at best hypothesis-generating, and the effect of nutritional intervention on clinical out-
comes must be confirmed in further randomized-controlled clinical trials.
Conclusions
Poor nutritional status as assessed by NRI and quartile grading of NRI was associated with
1-year mortality in Korean patients with ADHF. In addition, NRI was one of the independent
predictors of 1-year mortality. The assessment of nutritional status by NRI may provide addi-
tional prognostic information and thus would be useful in the risk stratification of the patients
with ADHF. NRI should be incorporated into novel risk scoring system for prediction of clini-
cal outcomes in patients with ADHF. Furthermore, well designed randomized trial assessing
the effect of nutritional intervention for HF patients would be warranted in the future.
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